Key facts
- It has raised $11.9M; the latest was Later Stage VC ($10.9M) in Apr 2025.
- Notable investors include Noordelijke Ontwikkelings Maatschappij, RUG Ventures, EUREKA Eurostars, Hanzepoort, Medlim — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Implican
- ·The full record, as it builds
Funding rounds
No funding rounds for Implican are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Implican
Developer of an anastomotic device designed to reduce anastomotic leakage. The company's device is based on compression and fixation of the bowel wall with the use of two rings, and using this compression, the wound will heal by primary intent, resulting in reduced anastomotic leakage, enabling surgeons to reduce complications during abdominal surgery.
- Sector
- Healthcare
- HQ
- Groningen, Netherlands
- Founded
- 2016
- Employees
- 5
- Website
- implican.nl/
- Ownership
- Privately Held (backing)
Implican doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Implican shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Implican in its N-PORT filings yet. We sweep new filings monthly.